Center for Financing, Access, and Cost Trends (CFACT): Publications by Staff

Marie N. Stagnitti

Author: Stagnitti M
Title: Trends in health care expenditures by Body Mass Index (BMI) category for adults in the U.S. civilian noninstitutionalized population, 2001 and 2006
Publication: MEPS Statistical Brief No. 247. Available on the MEPS Web site.
Date: July 2009
Abstract: The Brief compares, for the adult population, 2001 and 2006 total numbers of persons, total health care expenditures, and percentages of the population and total expenditures by BMI category. When comparing 2001 with 2006, the proportion of the adult obese population increased from 23.6 percent to 27.2 percent and the proportion of the adult population that was normal weight decreased (39.0 percent and 36.1 percent). When comparing 2001 and 2006 total expenditures for adults by BMI category a similar trend occurred.

Author: Stagnitti M
Title: Prescription drug estimates for Medicare beneficiaries, 2005 and 2006
Publication: MEPS Statistical Brief No. 240. Available on the MEPS Web site.
Date: March 2009
Abstract: For the years 2005 and 2006, this Brief presents the number of persons who reported having Medicare as well as total outpatient prescribed drug expenditures for the total population and the Medicare population. The Brief also compares the proportion of the Medicare population that reported at least one drug purchase and the proportion that had at least one Medicare payment for a prescribed drug. Moreover, the Brief compares the proportion of 2005 and 2006 total prescribed drug expenditures by source of payment for the Medicare population, and presents the average Medicare expenditure for prescribed drugs for the Medicare population for 2005 and 2006.

Author: Stagnitti M
Title: Trends in outpatient prescription analgesics utilization and expenditures for the U.S. civilian noninstitutionalized population, 1996 and 2006
Publication: MEPS Statistical Brief No. 235. Available on the MEPS Web site.
Date: February 2009
Abstract: This statistical brief presents trends in utilization and expenditures for outpatient prescription analgesics (pain relievers, medicines that treat aches and pains) for the years 1996 and 2006. For outpatient prescription analgesics, the brief compares 1996 and 2006 total expenditures, total number of purchases, and total number of persons purchasing, as well as average annual expenditure per person with a purchase and average expenditure per purchase.

Authors: Stagnitti M, Beauregard K, Solis A
Title: Design, methods, and field results of the Medical Expenditure Panel Survey Medical Provider Component (MEPS MPC)—2006 calendar year data
Publication: MEPS Methodology Report No. 23. Available on the MEPS Web site.
Date: November 2008
Abstract: This report focuses on the Medical Provider Component (MPC) data collection effort that collected information from medical providers that provided medical care to Household Component (HC) sampled persons on health care events that took place between January 1, 2006, and December 31, 2006.

Author: Stagnitti M
Title: Antidepressants prescribed by medical doctors in office based and outpatient settings by specialty for the U.S. civilian noninstitutionalized population, 2002 and 2005
Publication: MEPS Statistical Brief No. 206. Available on the MEPS Web site
Date: June 2008
Abstract: The estimates in this brief are derived from the Household Component of the 2002 and 2005 Medical Expenditure Panel Survey (MEPS-HC). The brief provides, by medical doctor specialty, estimates as reported by households on the percentage of prescriptions (not including refills) of antidepressants prescribed during office based and outpatient visits where a medical doctor spoke with the patient either in person or over the telephone.

Author: Stagnitti M
Title: Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005
Publication: MEPS Statistical Brief No. 205. Available on the MEPS Web site
Date: May 2008
Abstract: This statistical brief presents data on statins in the U.S. civilian noninstitutionalized population from the MEPS-HC in 2000 and 2005. The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditures and average number of purchases of statins for those with one or more statin purchases.

Author: Stagnitti M
Title: Comparing population characteristics of persons purchasing prescribed drugs from mail order pharmacies with persons purchasing prescribed drugs from other outlets, 2005
Publication: MEPS Statistical Brief No. 200. Available on the MEPS Web site
Date: February 2008
Abstract: The estimates in this brief are derived from the Household Component of the 2000 and the 2005 MEPS-HC. The brief provides information as reported by households in the U.S. civilian noninstitutionalized (community) population for calendar years 2000 and 2005 on the proportion of persons who purchased at least one prescribed medicine at the following types of pharmacies: mail order; drug store; HMO, clinic, or hospital; and another store (e.g., grocery store, etc.). This brief also compares person characteristics of those persons with a prescribed medicine expense purchasing at least one drug from a mail order pharmacy with the person characteristics of those purchasing at least one drug from other outlets in 2005.

Author: Stagnitti M
Title: The top five outpatient prescription drugs ranked by total expense for the Medicare beneficiaries, by insurance status, 2004
Publication: MEPS Statistical Brief No. 186. Available on the MEPS Web site
Date: October 2007
Abstract: Using data from the MEPS-HC, this Statistical Brief provides information on the top five outpatient prescription medicines ranked by total expenditures and insurance status for the Medicare population, as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2004, as well as information on average total payments and average out-of-pocket payments per purchase for the top five drugs for Medicare beneficiaries, by insurance status. Only prescribed medicines purchases in an outpatient setting are included in the estimates. Insulin and diabetic supplies and equipment are included in MEPS prescribed medicines estimates. Over-the-counter medicines are excluded from these estimates as are prescription medicines administered in an inpatient setting or in a clinic or physician's office.

Author: Stagnitti M
Title: The top five outpatient prescription drugs ranked by total expense for children, adults, and the elderly, 2004
Publication: MEPS Statistical Brief No. 180. Available on the MEPS Web site
Date: July 2007
Abstract: Using data from the MEPS-HC, this statistical brief provides information on the top five outpatient prescription medicines ranked by total expenditures as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2004 for children age 17 and under, adults age 18-64, and the elderly age 65 and older, as well as information on average total payment and average out-of-pocket payment per purchase for the top five drugs for each subpopulation. Only prescribed medicines purchases in an outpatient setting are included in the estimates. Insulin and diabetic supplies and equipment are included in MEPS prescribed medicines estimates. Over-the-counter medicines are excluded from these estimates as are prescription medicines administered in an inpatient setting or in a clinic or physician's office.

Author: Stagnitti M
Title: Trends in outpatient prescription drug utilization and expenditures: 1997 and 2004
Publication: MEPS Statistical Brief No. 168. Available on the MEPS Web site
Date: April 2007
Abstract: This statistical brief compares 1997 and 2004 estimates for the U.S. civilian noninstitutionalized (community) population from the MEPS-HC on total expenditures, total number of purchases, average total expenditure, average out-of-pocket payment, and average number of purchases for outpatient-prescribed medicines for those with a prescribed drug purchase. This brief also provides the percentage of total health care expenditures represented by prescribed drug expenditures for 1997 and 2004.

Author: Stagnitti M
Title: Trends in the use and expenditures for the therapeutic class prescribed psychotherapeutic agents and all subclasses, 1997 and 2004
Publication: MEPS Statistical Brief No. 163. Available on the MEPS Web site
Date: February 26, 2007
Abstract: This statistical brief compares 1997 and 2004 data for the U.S. civilian noninstitutionalized (community) population from the MEPS-HC on total expenditures, total number of purchases, total number of people with a purchase, and average price per purchase for the therapeutic class of prescribed psychotherapeutic agents and all therapeutic subclasses within the class. The subclasses include antipsychotics; central nervous system (CNS) stimulants; antidepressants; and anxiolytics, sedatives, and hypnotics.

Author: Stagnitti M
Title: The top five therapeutic classes of outpatient prescription drugs ranked by total expense for adults age 18 and older in the U.S. civilian noninstitutionalized population, 2004
Publication: MEPS Statistical Brief No. 154. Available on the MEPS Web site
Date: December 28, 2006
Abstract: Using data from the MEPS-HC, this statistical brief provides a summary of the top five therapeutic classes of outpatient prescription drugs for adults age 18 and older when ranked by total expense, as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2004, as well as estimates for the population age 18 and older on the percentage of annual prescribed drug expenses the top five therapeutic classes represented, the percentage of those with a prescribed drug expense having an expense in these classes of drugs, and the mean expense in these classes of drugs.

Author: Stagnitti M
Title: The top five therapeutic classes of outpatient prescription drugs ranked by total expense for the Medicare population age 65 and older in the U.S. civilian noninstitutionalized population, 2004
Publication: MEPS Statistical Brief No. 153. Available on the MEPS Web site
Date: December 28, 2006
Abstract: Using data from the 2004 MEPS-HC, this statistical brief provides a summary of the top five therapeutic classes of outpatient prescription drugs for Medicare beneficiaries age 65 and older when ranked by total expense, as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2004, as well as estimates for the Medicare population age 65 and older on the percentage of annual prescribed drug expenses the top five therapeutic classes represented, the percentage of those with a prescribed drug expense having an expense in these classes of drugs, and the mean expense in these classes of drugs.

Author: Stagnitti M
Title: A comparison of person characteristics and reported conditions for adult Medicare beneficiaries with high and low annual prescription medicine expenditures, 2003 >
Publication: MEPS Statistical Brief No. 148. Available on the MEPS Web site
Date: November 28, 2006
Abstract: Using data from the 2003 MEPS-HC, this statistical brief compares selected sociodemographic person characteristics and reported chronic conditions for adult Medicare beneficiaries in the top 10 percent (the 10 percent of the population with the highest prescription drug spending) with those in the lower 50 percent (the 50 percent of the population with the lowest prescription drug spending) of the prescribed medicine expenditure distribution.

Author: Stagnitti M
Title: Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 and 2003
Publication: MEPS Statistical Brief No. 144. Available on the MEPS Web site
Date: October 2006
Abstract: Using data from the MEPS-HC, this statistical brief provides estimates on brand name and generic prescribed medicine utilization and expenditures in the U.S. civilian noninstitutionalized population in 1999 and 2003. Only prescribed drugs obtained in an outpatient setting are included in the estimates. Insulin and diabetic supplies and equipment are included in MEPS prescribed medicines estimates. Over-the-counter medicines are excluded as are prescription medicines administered in an inpatient setting or in a clinic or physician's office.

Author: Stagnitti M
Title: Health care expenses in the United States, 1996
Publication: MEPS Statistical Brief No. 138. Available on the MEPS Web site
Date: September 2006
Abstract: Using data for the U.S. civilian noninstitutionalized (community) population from the 2003 MEPS-HC, this statistical brief compares the population characteristics of Medicare beneficiaries having different levels of annual outpatient prescribed drug expenses. Estimates are presented in terms of the expense categories in the standard Medicare Prescription Drug Benefit in Medicare Part D (which began January 1, 2006). The expense categories have been deflated to 2003 dollars.

Author: Stagnitti M
Title: Outpatient prescription drug expenses in the U.S. community population, 2003
Publication: MEPS Chartbook No. 16. Available on the MEPS Web site
Date: June 2006
Abstract: This chartbook presents data from the 2003 MEPS on spending for outpatient prescription medicines for the U.S. civilian noninstitutionalized population with a focus on comparisons between the Medicare and non-Medicare populations.

Author: Stagnitti M
Title: Outpatient prescribed medicine expenses by source of payment and insurance status for the Medicare and non-Medicare populations, 2003
Publication: MEPS Statistical Brief No. 125. Available on the MEPS Web site
Date: May 2006
Abstract: This statistical brief presents 2003 data from the MEPS-HC for the Medicare and non-Medicare subpopulations in the U.S. civilian noninstitutionalized (community) population on prescribed medicine expenditures, by sources of payment and insurance status. Only prescribed medicine purchases in an outpatient setting are included in the estimates.

Author: Stagnitti M
Title: A comparison of antidiabetic agent prescribed medications: oral medicines and insulin, 1997 and 2003
Publication: MEPS Statistical Brief No. 118. Available on the MEPS Web site
Date: March 2006
Abstract: This statistical brief compares 1997 and 2003 data for the U.S. civilian noninstitutionalized population from the MEPS-HC on the total expenditures, total number of purchases, and number of people with purchases of prescribed antidiabetic medicines. In addition to the larger therapeutic subclass of prescribed antidiabetic agents, similar trend data are provided for two smaller groupings of prescribed medications that comprise the subclass of antidiabetic agents: insulin and oral antidiabetic medicines.

Author: Stagnitti M
Title: The top five therapeutic classes of outpatient prescription drugs ranked by total expenses for adults age 18 and older in the U.S. civilian noninstitutionalized population, 2003
Publication: MEPS Statistical Brief No. 110. Available on the MEPS Web site
Date: January 2006
Abstract: Using data from the 2003 MEPS-HC, this statistical brief provides a summary of the top five therapeutic classes of outpatient prescription drugs for adults age 18 and older when ranked by total expenses, as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2003, as well as estimates for the age 18 and older population on the percentage of annual prescribed drug expenses the top five therapeutic classes represent, the percentage of those with a prescribed drug expense having an expense in these classes of drugs, and the mean expenses in these classes of drugs.

Author: Stagnitti M
Title: The top five therapeutic classes of outpatient prescription drugs ranked by total expenses for the Medicare population age 65 and older in the U.S. civilian noninstitutionalized population, 2003
Publication: MEPS Statistical Brief No. 109. Available on the MEPS Web site
Date: January 2006
Abstract: Using data from the 2003 MEPS-HC, this statistical brief provides a summary of the top five therapeutic classes of outpatient prescription drugs for Medicare beneficiaries age 65 and older when ranked by total expenses, as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2003, as well as estimates for the Medicare population age 65 and older on the percentage of annual prescribed drug expenses the top five therapeutic classes represent, the percentage of those with a prescribed drug expense having an expense in these classes of drugs, and the mean expenses in these classes of drugs.

Authors: Crimmel B, Stagnitti M
Title: Prescription drugs: Out-of-pocket expenses and unmet need relative to family income, 2002
Publication: MEPS Statistical Brief No. 102. Available on the MEPS Web site
Date: October 2005
Abstract: Using data from the 2002 MEPS-HC, this statistical brief discusses out-of-pocket expenses and unmet need related to obtaining prescription drugs for the U.S. civilian noninstitutionalized (community) population in 2002. The analysis examines these topics relative to family income for families with out-of-pocket expenses less than or equal to 5 percent of income and for those with expenses greater than 5 percent of income. Results are provided separately for families with an elderly member (a person age 65 or older) and for families without an elderly member.

Authors: Miller GE, Stagnitti M
Title: Trends in statin use in the civilian noninstitutionalized Medicare population, 1997 and 2002
Publication: MEPS Statistical Brief No. 97. Available on the MEPS Web site
Date: September 2005
Abstract: This statistical brief presents data from MEPS-HC on statin use in the U.S. civilian noninstitutionalized Medicare population in 1997 and 2002. Estimates are presented for subgroups of the Medicare population defined by age, race/ethnicity, sex, poverty status, insurance status, and health status.

Authors: Miller GE, Stagnitti M
Title: Statin use in the civilian noninstitutionalized Medicare population in 2002
Publication: MEPS Statistical Brief No. 96. Available on the MEPS Web site
Date: September 2005
Abstract: This statistical brief presents data from the MEPS-HC on statin use in the civilian noninstitutionalized Medicare population in 2002. Estimates are presented for subgroups of this population defined by sex, age, race/ethnicity, insurance status, poverty status, and health status.

Author: Stagnitti M
Title: Statin use among persons 18 and older in the U.S. civilian noninstitutionalized population reported as receiving medical care for the treatment of high cholesterol, 2002
Publication: MEPS Statistical Brief No. 95. Available on the MEPS Web site
Date: September 2005
Abstract: Using data from the MEPS-HC for 2002, this statistical brief provides estimates of persons with high cholesterol who were using a statin by selected demographic and socioeconomic characteristics, including age, race/ethnicity, and insurance status.

Author: Stagnitti M
Title: The top five therapeutic classes of outpatient prescription drugs, by total expenses for the elderly and near elderly in the U.S. civilian noninstitutionalized population, 2002
Publication: MEPS Statistical Brief No. 91. Available on the MEPS Web site
Date: July 2005
Abstract: Using data from the MEPS-HC, this statistical brief provides a summary of the top five therapeutic classes of outpatient prescription drugs for the elderly (age 65 and older) and the near elderly (age 55-64), when ranked by total expenses, as reported by households in the U.S. civilian noninstitutionalized population in calendar year 2002, as well as estimates for these population groups on the percentage of total prescribed drug expenses the top five therapeutic classes represent, the percentage having an expense in these classes of drugs, and the mean expenses in these classes of drugs for those with an expense.

Author: Stagnitti M
Title: Antidepressant use in the U.S. civilian noninstitutionalized population, 2002
Publication: MEPS Statistical Brief No. 77. Available on the MEPS Web site
Date: May 2005
Abstract: Using data from the 2002 MEPS-HC, this statistical brief examines variations in the percentage of persons in the U.S. civilian noninstitutionalized population who used antidepressants in 2002, by select person characteristics. The person characteristics analyzed in the brief include age, race/ethnicity, sex, insurance status, perceived health status, perceived mental health status, and marital status.

Author: Stagnitti M
Title: Trends in antidepressant use by the U.S. civilian noninstitutionalized population, 1997 and 2002
Publication: MEPS Statistical Brief No. 76. Available on the MEPS Web site
Date: May 2005
Abstract: Using data from the MEPS-HC, this statistical brief summarizes data that indicate a significant growth in the use of antidepressants among the U.S. civilian noninstitutionalized (community) population when comparing the years 1997 and 2002. The brief further compares estimates of antidepressant use by various demographic and socioeconomic subgroups of the U.S. community population over the same time period.

Author: Stagnitti M
Title: Top 10 outpatient prescription medicines ranked by utilization and expenditures for the elderly in the U.S. community population, 2002
Publication: MEPS Statistical Brief No. 66. Available on the MEPS Web site
Date: February 2005
Abstract: Using prescribed medicine data in the MEPS-HC, this statistical brief provides a summary of the top 10 outpatient prescription medicines for the elderly (65 and older) in the U.S. community population in 2002, by utilization and expenditures. The brief also provides trends in annual prescribed medicines expenditures for the elderly from 1996 to 2002.

Author: Stagnitti M
Title: Top 10 outpatient prescription medicines ranked by utilization and expenditures for the near elderly in the U.S. community population, 2002
Publication: MEPS Statistical Brief No. 65. Available on the MEPS Web site
Date: February 2005
Abstract: Using prescribed medicine data in the MEPS-HC, this statistical brief provides a summary of the top 10 outpatient prescription medicines for the near elderly (55 to 64) in the U.S. community population in 2002, by utilization and expenditures. The brief also provides trends in annual prescribed medicines expenditures for the near elderly from 1996 to 2002.

Author: Stagnitti M
Title: Top 10 outpatient prescription medicines ranked by utilization and expenditures for the U.S. community population, 2002
Publication: MEPS Statistical Brief No. 60. Available on the MEPS Web site
Date: December 2004
Abstract: Using estimates derived from the 2002 MEPS-HC, this statistical brief provides a summary of the top 10 outpatient prescription medicines by utilization and expenditures as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2002.

Author: Stagnitti M, Pancholi M
Title: Chronic conditions and outpatient prescription medicines for persons 18 and older in the U.S. civilian noninstitutionalized population, 1987 and 2001
Publication: MEPS Statistical Brief No. 58. Available on the MEPS Web site
Date: December 2004
Abstract: Using data from the 1987 National Medical Expenditure Survey (NMES) and the 2001 MEPS-HC, this statistical brief compares estimates from 1987 and 2001 on the use of prescribed medicines in the U.S. civilian noninstitutionalized (community) age 18 and older (adult) population as part of the treatment for specific chronic conditions.

Authors: Stagnitti M, Pancholi M
Title: Outpatient prescription medicines: A comparison of expenditures by household-reported condition, 1987 and 2001
Publication: MEPS Statistical Brief No. 43. Available on the MEPS Web site
Date: July 2004
Abstract: This statistical brief summarizes differences in expenditures for outpatient prescription medicines reported for specific conditions by the household in the U.S. civilian noninstitutionalized population for the years 1987 and 2001. The data used are derived from the 1987 NMES and the 2001 MEPS-HC.

Author: Stagnitti M
Title: The prevalence of obesity and other chronic health conditions among diabetic adults in the U.S. community population, 2001
Publication: MEPS Statistical Brief No. 34. Available on the MEPS Web site
Date: 2004
Abstract: This statistical brief presents preliminary estimates of the relationship between diabetes, obesity, and other chronic conditions among adults in the U.S. community population. Body mass index (BMI) was used to categorize people into weight categories. Data concerning the U.S. community population are derived from the 2001 MEPS-HC and expenditure estimates from the 2000 MEPS Compendium of Tables.

Authors: Pancholi M, Stagnitti M
Title: Outpatient prescribed medicines: a comparison of use and expenditures, 1987 and 2001
Publication: MEPS Statistical Brief No. 33. Available on the MEPS Web site
Date: 2004
Abstract: This statistical brief summarizes data that indicate a significant growth between 1987 and 2001 in the use (i.e., number of purchases) and expenditures for outpatient prescribed medicines in the U.S. civilian noninstitutionalized population. The data used are derived from the 1987 NMES and the 2001 MEPS-HC. The estimates from the 1987 NMES were adjusted for inflation using data from the 1987 and 2001 Consumer Price Index for All Urban Consumers (CPI-U).

Authors: Stagnitti M, Miller GE, Moeller J
Title: Outpatient prescription drug expenses, 1999
Publication: MEPS Chartbook No. 12. AHRQ Pub. No. 04-0001. Available on the MEPS Web site
Date: 2003
Abstract: This chartbook presents data from the 1999 MEPS on spending for outpatient prescription medicines for the U.S. civilian noninstitutionalized population. This chartbook is organized into three sections. Section 1 presents a summary of overall outpatient prescription medicine expenses and payments. Section 2 contains outpatient prescription medicine expenses and payments by various population groups. Section 3 contains expenses on outpatient prescription drugs by therapeutic class.

Author: Stagnitti M
Title: Trends in outpatient prescription drug utilization and expenditures: 1997-2000
Publication: MEPS Statistical Brief No. 21. Available on the MEPS Web site
Date: 2003
Abstract: This statistical brief summarizes data concerning prescribed medicines utilization and expenditures for the U.S. civilian noninstitutionalized population for the years 1997-2000, as derived from the 1997-2000 Full Year Consolidated Data Files (HC-051, HC-038, HC-028, and HC-020). In MEPS, prescribed medicine utilization is defined as a prescription medicine purchase.

Author: Stagnitti M
Title: Medical care and treatment for chronic conditions, 2000
Publication: MEPS Statistical Brief No. 5. Available on the MEPS Web site
Date: 2002
Abstract: This statistical brief presents preliminary analyses of the treatment regimens for individuals with selected chronic conditions based on data from the 2000 MEPS. Medical care/treatment for persons 18 or older with diabetes, cardiovascular disease, asthma, stroke, and high blood pressure are examined (all coverage estimates based on health insurance status for the first part of 2000). All results discussed in this statistical brief are statistically significant at the 0.05 level.

Authors: Moeller J, Stagnitti M, Horan E, et al
Title: Outpatient prescription drugs: Data collection and editing in the 1996 Medical Expenditure Panel Survey (HC-010A)
Publication: MEPS Methodology Report No. 12. AHRQ Pub. No. 01-0002. Available on the MEPS Web site
Date: 2001
Abstract: MEPS is the third in a series of nationally representative surveys of medical care use and expenditures sponsored by AHRQ. For the first time in a national expenditure survey, the 1996 MEPS included a detailed collection of information on prescription medicines obtained from pharmacy providers frequented by household sampled persons. The information was collected by means of a linked survey of pharmacy providers. This report describes the procedures adopted to collect and edit these prescription drug data for public release. It includes efforts made to retrieve complete and/or partially missing pharmacy data, the editing techniques used to fill in remaining missing data in the pharmacy database, and the matching/imputation procedure that linked every prescription drug mentioned by the respondent in the MEPS Household Component to a specific prescription drug from the Pharmacy Component (part of the Medical Provider Component).

Authors: McCormick M, Weinick R, Elixhauser A, et al.
Title: Annual report on access to and utilization of health care for children and youth in the United States—2000
Publication: Ambul Pediatr 1(1):3-15. AHRQ Pub. No. 01-R036
Date: 2001
Abstract: Available on PubMed®

Authors: Cohen J, Machlin S, Zuvekas S, et al
Title: Health care expenses in the United States, 1996
Publication: MEPS Research Findings No. 12. AHRQ Pub. No. 01-0009. Available on the MEPS Web site
Date: 2000
Abstract: This report presents descriptive data on health care spending in the United States. Data come from the 1996 MEPS and cover the civilian noninstitutionalized U.S. population. Information is given on total health care expenses combined and also for hospital inpatient services, ambulatory services, prescription medicines, dental services, home health services, and other medical equipment and supplies.

---

 Previous Section       CFACT Author Index       Next Section 

---